NasdaqCM - Nasdaq Real Time Price USD
Phio Pharmaceuticals Corp. (PHIO)
1.7700
-0.0300
(-1.70%)
As of 2:32:40 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | 4.3 | 0 |
| Low Estimate | 0 | 0 | 4.3 | 0 |
| High Estimate | 0 | 0 | 4.3 | 0 |
| Year Ago EPS | -- | -- | -- | 4.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 75M | -- |
| Low Estimate | -- | -- | 75M | -- |
| High Estimate | -- | -- | 75M | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -4.59 | -4.14 | -1.23 |
| EPS Actual | -4.23 | -3.62 | -1.54 | -0.85 |
| Difference | -- | 0.97 | 2.6 | 0.38 |
| Surprise % | -- | 21.13% | 62.80% | 30.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 4.3 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PHIO | -- | -- | -- | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2023 |
Related Tickers
ZVSA ZyVersa Therapeutics, Inc.
0.5100
-10.71%
GLMD Galmed Pharmaceuticals Ltd.
1.2401
-0.79%
TOVX Theriva Biologics, Inc.
0.5202
-19.12%
HEPA Hepion Pharmaceuticals, Inc.
0.3950
+0.26%
IBO Impact BioMedical Inc.
0.5567
+11.89%
SPRC SciSparc Ltd.
0.3421
-0.12%
KTTA Pasithea Therapeutics Corp.
0.8156
-15.04%
ADIL Adial Pharmaceuticals, Inc.
0.6200
0.00%
ELAB PMGC Holdings Inc.
2.3200
-1.28%
PTIX Protagenic Therapeutics, Inc.
3.2900
-6.00%